Association Between Serum Cystatin C Levels and Coronary Slow Flow
- 7 October 2013
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 65 (9), 831-837
- https://doi.org/10.1177/0003319713505697
Abstract
We assessed the association between serum cystatin C (CysC) levels and coronary slow flow (CSF) phenomenon in patients who underwent coronary angiography. A total of 210 patients (mean age 55.6 ± 10.9 years; 100 females) were included. Patients were divided into 3 groups, (patients with CSF [group 2], with coronary artery disease [CAD; group 3], and without CAD [group 1]). Serum CysC levels in patients with CSF were significantly lower than those with and without CAD (912.5 ± 135.6, 820.4 ± 104.2, and 1343.4 ± 236.6 ng/mL in groups 1, 2, and 3, respectively; P < .001). Serum CysC levels correlated with the number of vessels with CSF and mean corrected thrombolysis in myocardial infarction frame count (Spearman correlation coefficient [ rs] = .192, P < .001 and rs = .261, P < .001 respectively). In conclusion, patients with CSF have lower CysC levels; this could be a useful biomarker of CSF involvement in patients who undergo diagnostic coronary angiography.Keywords
This publication has 33 references indexed in Scilit:
- Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosisThrombosis and Haemostasis, 2012
- ST/T wave changes during acute coronary syndrome presentation in patients with the coronary slow flow phenomenonInternational Journal of Cardiology, 2011
- Clinical Prognostic Significance of Plasma Cystatin C Levels among Patients With Acute Coronary SyndromeClinical Cardiology, 2009
- Clinical and coronary angiographic characteristics of patients with coronary slow flowActa Cardiologica, 2008
- Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flowCoronary Artery Disease, 2007
- Increased plasma levels of cystatin C and transforming growth factor-β1 in patients with coronary artery ectasia: can there be a potential interaction between cystatin C and transforming growth factor-β1Coronary Artery Disease, 2007
- Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart DiseaseCirculation, 2007
- Elevated level of plasma homocysteine in patients with slow coronary flowInternational Journal of Cardiology, 2005
- Elevated plasma homocysteine level in slow coronary flowInternational Journal of Cardiology, 2005
- Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenonAmerican Heart Journal, 2003